+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Impact of ganciclovir prophylaxis on CMV infection in cadaveric renal allograft recipients



Impact of ganciclovir prophylaxis on CMV infection in cadaveric renal allograft recipients



Journal of the American Society of Nephrology 5(3): 1032




(PDF emailed within 1 workday: $29.90)

Accession: 031829469

Download citation: RISBibTeXText


Related references

Impact of ganciclovir prophylaxis on cytomegalovirus infection in recipients of cadaveric renal allografts. Nephron 76(1): 49-55, 1997

Impact of Ganciclovir Prophylaxis on Cytomegalovirus Infection in Recipients of Cadaveric Renal Al log rafts. Nephron 76(1): 49-55, 1997

Therapeutic use of ganciclovir for invasive cytomegalovirus infection in cadaveric renal allograft recipients. Journal of Urology 148(5): 1388-1392, 1992

Prophylaxis of CMV disease by ganciclovir (DHPG) in seronegative recipients of renal allograft from seropositive donors. Transplant International 5 Suppl 1: S30-S31, 1992

Prophylaxis of Cmv disease by ganciclovir (Dhpg) in seronegative recipients of renal allograft from seropositive donors. Transplant International 5: S30-S31, 1992

Ganciclovir for cytomegalovirus cmv infection in renal allograft recipients. Journal of Urology 145(4 SUPPL): 304A, 1991

Ganciclovir for invasive cytomegalovirus infection in renal allograft recipients. Transplantation Proceedings 23(1 Pt 2): 1346-1347, 1991

The impact of ganciclovir prophylaxis on heart-lung and lung allograft recipients. Journal of Heart & Lung Transplantation 14(1 PART 2): S67, 1995

Late cytomegalovirus infection after oral ganciclovir prophylaxis in renal transplant recipients. Transplant Infectious Disease 6(1): 3-9, 2004

Ganciclovir prophylaxis delays but does not prevent cytomegalovirus infection in renal transplant recipients. Transplantation Proceedings 36(10): 3019-3024, 2005

Risk factors for cytomegalovirus disease in high risk renal allograft recipients under oral ganciclovir prophylaxis. Nephrology Dialysis Transplantation 16(6): A219, 2001

Treatment of active CMV infection with oral ganciclovir in renal allograft recipients Monitoring efficacy with quantitative CMV-PCR. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 719A-720A, 2000

Treatment of active CMV infection in renal allograft recipients with oral ganciclovir Monitoring efficacy using quantitative CMV-PCR. Journal of Investigative Medicine 49(1): 48A, 2001

HIV infection in cadaveric renal allograft recipients in the North Italy Transplant Program. Transplantation 47(4): 724-725, 1989

Impact of HLA CREG and DR mismatches on graft survival and rejection in cadaveric renal allograft recipients. Human Immunology 60(SUPPL 2): S16, 1999